CC
NBSE

Cannell & Co’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Cannell & Co’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,230
Closed -$915K – 263
2017
Q4 		$915K Buy
1,230
+498
+68% +$370K 0.03% 173
2017
Q3 		$211K Hold
732
– – 0.01% 232
2017
Q2 		$187K Buy
+732
New +$187K 0.01% 236